LHX2 is a transcription factor and a mesenchymal marker of epithelial-mesenchymal transition (EMT), which has been reported to promote tumor growth and metastasis in pancreatic ductal adenocarcinoma and breast cancer 22, 23. The gene discussed is LHX2; the disease is pancreatic ductal adenocarcinoma.